MGMA16: helping medical practice leaders thrive

MGMA16: helping medical practice leaders thrive


MGMA16 (Medical Group Management Association) San Francisco kicked off on Sunday with six pre-conference sessions. General sessions opened on Monday to approximately 5,000 attendees comprised of: practice administrators and executives, providers, and vendors, with organizations of all sizes, from 2-10,000 providers. Monday morning’s main stage session was delivered by author David H. Pink, New York Times Bestselling author of A Whole New Mind, who shared key skills that organizations will need in today’s healthcare transformation era. Regardless of your role it will be critical to look at basic communication skills as your foundation with a focus on: listening, persuasion, influence, selling, and looking at everyone’s perspective.  These skills will all be instrumental in achieving your organizational goals all while keeping a keen eye on today’s culture. It’s a lot to take in!

daniel-h-pink

David H. Pink, NY Times Bestseller, speaking about the complicated nature of change

The educational sessions this year fall into six main areas for attendees to learn, share, and network:

Content areas:

  • Working within the Value Based World
  • The Independent to Integrated Spectrum
  • The Changing Patient Relationship
  • People Leadership
  • Maximizing the Benefits of Third-Party Relationships
  • Government Affairs

There are over 85 educational sessions for attendees to choose from over the 2 1/2 days of the conference which ends Wednesday. Here’s a quick glance at some of the great sessions I attended and learned from today!

mgma16

Which ACO Partnership is right for you!

  • Collaboration and trust are integral components in selecting and setting up your ACO
  • Submitting quality data isn’t enough, you have to consider costs

Of course, the last point brought up a great discussion by a provider who raised the concern of generic drug utilization versus new brand new drugs. The end-point being that often times the generic older drugs don’t have the same patient outcomes as the newer ones, indicating that sometimes paying more is warranted to get the end result. I thought this was an excellent point. As medical advances come along, often at a higher price, many people would likely pay a bit more up front for the desired outcome, versus the lower cost medication with poorer outcomes that could even end up with hospitalization. The discussion ended with bullet 1: it’s all about collaboration and trust with your payer and group, in order to have meaningful decisions, and if we truly want to improve our healthcare outcomes in this country.

Under the MACRAscope-MIPS

MGMA presented the first of a 3-part session on MACRA. Suffice to say the room was packed—with standing room only! Many practices are trying to understand the final rule that was released on October 14, 2016. The good news is 2017 is a transition year so regardless if you are a small practice or a large organization there are options to succeed as long as you do something! Doing nothing will result in a 4% penalty!

Excellent examples of how each category for 2017 was outlined: Quality, Advancing Care Information (formerly known as MU to most), and the new category—Improvement Activities, which will breakdown, along with the reporting options, scoring and performance benchmarks for each one.

mips-timeline

Day 1 ends with a Black and White Masquerade, naturally in honor of Halloween! Looking forward to more sharing, learning, and networking on Day two! Questions? Contact us below:

Facebook Twitter Email

+ There are no comments

Add yours